MVM
CNTA
Medicxi Ventures Management’s Centessa Pharmaceuticals CNTA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $262M | Hold |
19,963,157
| – | – | 61.4% | 1 |
|
2025
Q1 | $287M | Hold |
19,963,157
| – | – | 65.59% | 1 |
|
2024
Q4 | $334M | Hold |
19,963,157
| – | – | 63.2% | 1 |
|
2024
Q3 | $319M | Hold |
19,963,157
| – | – | 60.35% | 1 |
|
2024
Q2 | $180M | Hold |
19,963,157
| – | – | 53.77% | 1 |
|
2024
Q1 | $226M | Hold |
19,963,157
| – | – | 50.22% | 1 |
|
2023
Q4 | $159M | Hold |
19,963,157
| – | – | 53.64% | 1 |
|
2023
Q3 | $129M | Hold |
19,963,157
| – | – | 41.24% | 1 |
|
2023
Q2 | $124M | Hold |
19,963,157
| – | – | 34.62% | 1 |
|
2023
Q1 | $76.9M | Hold |
19,963,157
| – | – | 32.93% | 1 |
|
2022
Q4 | $61.9M | Hold |
19,963,157
| – | – | 25.99% | 2 |
|
2022
Q3 | $80.3M | Hold |
19,963,157
| – | – | 33.41% | 1 |
|
2022
Q2 | $97.2M | Hold |
19,963,157
| – | – | 40.37% | 1 |
|
2022
Q1 | $179M | Buy |
19,963,157
+1,839,265
| +10% | +$16.5M | 48.51% | 1 |
|
2021
Q4 | $204M | Buy |
18,123,892
+200,000
| +1% | +$2.25M | 51.07% | 1 |
|
2021
Q3 | $299M | Hold |
17,923,892
| – | – | 65.12% | 1 |
|
2021
Q2 | $398M | Buy |
+17,923,892
| New | +$398M | 71.34% | 1 |
|